Abstract

Effective pulp-capping materials should possess properties to induce the formation of reparative dentin to preserve vital dental pulp. However, many current biomaterials ignore the anti-inflammatory effect during pulp capping treatment. In this study, dexamethasone (DEX) was used as an anti-inflammatory and osteogenic drug, and was encapsulated by mesoporous silica-loaded nanohydroxyapatite (na-HAp) to form MSN@na-HAp-DEX. The characteristics of MSN@na-HAp-DEX, its effects on human dental pulp stem cells (hDPSCs) viability, anti-inflammatory, differentiation induction were examined. MSN@na-HAp-DEX presented a typical core–shell structure with a nanosize and a large specific surface area and was successfully loaded with DEX. The hDPSCs exposed to MSN@na-HAp-DEX showed good cell viability at three days and stronger ALP activity with more calcium deposition in vitro. In addition, the expression of odontogenesis-related genes exposed to MSN@na-HAp-DEX were significantly upregulated and the expression of inflammatory genes were significantly downregulated in vitro. Meanwhile, MSN@na-HAp-DEX showed good cytocompatibility and induced mineralized tissue to preserve the dental pulp in a direct pulp-capping model in rat. This novel direct pulp capping nanomaterial loading DEX is expected to an alternative for conventional materials.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call